▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

CVS Health Q2 19 Earnings Conference Call At 8:00 AM ET

By RTTNews Staff Writer ✉ | Published: 8/7/2019 7:00 AM ET

CVS Health Corp. (CVS) will host a conference call at 8:00 AM ET on August 7, 2019, to discuss Q2 19 earnings results.

To access the live webcast, log on to http://investors.cvshealth.com

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks Facing FDA Decision In December 2019

Biosimilar Race US Lags Behind Europe

Top Ten Cannabiz Celebrities

Profile Design Recalls Bicycle Carbon Aerobars

Lufthansa Group November Sales, Load Factor Rise - Quick Facts

University Of Phoenix To Pay $191 Mln To Settle FTC Charges For Deceptive Ads

GM Introduces All-new Tahoe And Suburban

Interest-free Installments For IPhone From Apple Card

Facebook's 'Portal' Adds More Features

Ruiz Food Recalls Frozen Breakfast Burrito Over Possible Plastic Presence

Bass Pro Recalls 'Mr. Steak' Gas Grills

Stock Alert : Midstream Stocks Showing Momentum (DCP, ENLC)

Chipotle Offering Free Burritos

CVS Health Q2 19 Earnings Conference Call At 8:00 AM ET

Profile Design Recalls Bicycle Carbon Aerobars

Lufthansa Group November Sales, Load Factor Rise - Quick Facts

University Of Phoenix To Pay $191 Mln To Settle FTC Charges For Deceptive Ads

GM Introduces All-new Tahoe And Suburban

Interest-free Installments For IPhone From Apple Card

Facebook's 'Portal' Adds More Features

Ruiz Food Recalls Frozen Breakfast Burrito Over Possible Plastic Presence

Bass Pro Recalls 'Mr. Steak' Gas Grills

Stock Alert : Midstream Stocks Showing Momentum (DCP, ENLC)

Chipotle Offering Free Burritos

Walmart Apologizes For Christmas Sweater Featuring Santa With Cocaine

Ford Recalls 262K Heavy Duty Trucks For Electric Tailgate Issue

Axel Springer: KKR's Tender Offer Receives Last Outstanding Merger Clearance

Globus Medical's (GMED) Got A Spine...

APTO On The Move, PLX To Effect Reverse Split, SCYX Plunges

Top Gainers: THOR Acquired, FTSV Up On Magrolimab Data, Investors Believe FATE

At The ASH 2019 Annual Meeting: AXLA, CBMG, SRRA, EPZM, STOK...

FDA Panel Says No To CORV, ITRM For Sure Has Disappointed, ELOX, XERS On Watch

Roche Gets CE Mark For Its Accu-Chek SugarView App - Quick Facts

Merck To Acquire ArQule For $20/share In Cash - Quick Facts

Stock To Watch: ObsEva's PRIMROSE 2 Trial Meets Goals

Texas Capital Bancshares And Independent Bank To Merge

Janssen To Buy Investigational Bermekimab From XBiotech

Amazon CEO Bezos Offers Support To Pentagon

Sanofi To Discontinue Research In Diabetes And Cardiovascular

National Grid Submits Business Plans To Ofgem - Quick Facts

Air France KLM Nov. Total Group Traffic Up 3.6% - Quick Facts

Roche Announces Changes In Board Of Directors

Sanofi Agrees To Buy Synthorx For $2.5 Bln - Quick Facts

Portola Pharma Presents News Phase IIa Study Of Cerdulatinib

Globus Medical's (GMED) Got A Spine...

Tesco Considers Sale Of Thai And Malaysian Stores

Maine Starts Taking Applications For Adult Use Marijuana Facilities

Janssen To Buy Investigational Bermekimab From XBiotech

Lilly Presents Interim Data From Trial In B-Cell Leukemias And Lymphomas

Ericsson Agrees To Pay More Than $1 Bln To Settle U.S. Corruption Probe